Phenytoin

•Transferir como PPTX, PDF•

0 gostou•420 visualizações

A

Antiepileptic drug-phenytoin uses,adverse effect, toxic effect,pro drug,fosphenytoin ,seizure

ANTIEPILEPTIC DRUH
•Phenytoin (Na channel
blocker)

PHOSPHENYTOIN-PRODRUG
•Water soluble prodrug
•Administration-IV/IM
•Use-Status epilepticus

AT TOXIC DOSES(ACUTE HIGH DOSE)
Cerebellar symptoms
*Ataxia
*Vertigo
*Nystagmus
*Diplopia

USES
*Generalised tonic-clonic seizure
*partial seizure
*Antiarrythmic drug
*Enhance wound healing
*Trigeminal neuralgia

ADVERSE EFFECTS •Gum hypertrophy
•Hirsutism
•Lymphadenopathy
•Teratogenic syndrome
•Megaloblastic anemia
•Hyperglycemia
•Osteomalecia/Rickets

Thank you

Mais conteúdo relacionado

Mais procurados

Barbiturates and benzodiazepines acute poisoning

Barbiturates and benzodiazepines acute poisoning

Barbiturates and benzodiazepines acute poisoning

Benzodiazepines

Benzodiazepines

Benzodiazepines

Adonis Sfera, MD

Anticonvulsants

Anticonvulsants

Anticonvulsants

Tandzile Simelane

Adrenergic drugs β adrenergic blocker

Adrenergic drugs β adrenergic blocker

Adrenergic drugs β adrenergic blocker

Subramani Parasuraman

Phenytoin

Antiepileptics

Kalaivanisathishr

Parasympathomimetic drugs

Parasympathomimetic drugs

Parasympathomimetic drugs

Dr Pralhad Patki

pharmacology of general anesthetics

pharmacology of general anesthetics

pharmacology of general anesthetics

Khyber Medical university

Class antiparkinsonian drugs

Class antiparkinsonian drugs

Class antiparkinsonian drugs

Anticholinesterases

Anticholinesterases

Anticholinesterases

Pharmacology - Parkinsonism

Pharmacology - Parkinsonism

Pharmacology - Parkinsonism

Nasal decongestants

Nasal decongestants

Nasal decongestants

Opioid receptors & opioid analgesics

Opioid receptors & opioid analgesics

Opioid receptors & opioid analgesics

Benzodiazepines

Benzodiazepines

Benzodiazepines

Antimalarial drugs

Antimalarial drugs

Antimalarial drugs

Pathophysiology and management of epilepsy

Pathophysiology and management of epilepsy

Pathophysiology and management of epilepsy

Soujanya Pharm.D

Anticonvulsant drugs

Anticonvulsant drugs

Anticonvulsant drugs

Diazepam

CNS stimulants and cognition enhancers

CNS stimulants and cognition enhancers

CNS stimulants and cognition enhancers

http://neigrihms.gov.in/

Adrenaline pharmacology

Adrenaline pharmacology

Adrenaline pharmacology

PARUL UNIVERSITY

Mais procurados (20)

Barbiturates and benzodiazepines acute poisoning

Barbiturates and benzodiazepines acute poisoning

Barbiturates and benzodiazepines acute poisoning

Benzodiazepines

Benzodiazepines

Benzodiazepines

Anticonvulsants

Anticonvulsants

Anticonvulsants

Adrenergic drugs β adrenergic blocker

Adrenergic drugs β adrenergic blocker

Adrenergic drugs β adrenergic blocker

Phenytoin

Antiepileptics

Parasympathomimetic drugs

Parasympathomimetic drugs

Parasympathomimetic drugs

pharmacology of general anesthetics

pharmacology of general anesthetics

pharmacology of general anesthetics

Class antiparkinsonian drugs

Class antiparkinsonian drugs

Class antiparkinsonian drugs

Anticholinesterases

Anticholinesterases

Anticholinesterases

Pharmacology - Parkinsonism

Pharmacology - Parkinsonism

Pharmacology - Parkinsonism

Nasal decongestants

Nasal decongestants

Nasal decongestants

Opioid receptors & opioid analgesics

Opioid receptors & opioid analgesics

Opioid receptors & opioid analgesics

Benzodiazepines

Benzodiazepines

Benzodiazepines

Antimalarial drugs

Antimalarial drugs

Antimalarial drugs

Pathophysiology and management of epilepsy

Pathophysiology and management of epilepsy

Pathophysiology and management of epilepsy

Anticonvulsant drugs

Anticonvulsant drugs

Anticonvulsant drugs

Diazepam

CNS stimulants and cognition enhancers

CNS stimulants and cognition enhancers

CNS stimulants and cognition enhancers

Adrenaline pharmacology

Adrenaline pharmacology

Adrenaline pharmacology

Último

Gardella_Mateo_IntellectualProperty.pdf.

Gardella_Mateo_IntellectualProperty.pdf.

Gardella_Mateo_IntellectualProperty.pdf.

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"

National Information Standards Organization (NISO)

In BC’s nearly-decade-old “new” curriculum, the curricular competencies describe the processes that students are expected to develop in areas of learning such as mathematics. They reflect the “Do” in the “Know-Do-Understand” model. Under the “Communicating” header falls the curricular competency “Explain and justify mathematical ideas and decisions.” Note that it contains two processes: “Explain mathematical ideas” and “Justify mathematical decisions.” I have broken it down into its separate parts in order to understand--or reveal--its meaning. The first part is commonplace in classrooms. By now, BC math teachers—and students—understand that “Explain mathematical ideas” means more than “Show your work.” Teachers consistently ask “What did you do?” and “How do you know?” This process is about retelling, not just of steps but of thinking. The second part happens less frequently. Think back to the last time that you observed a student make—a necessary precursor to justify—a mathematical decision. “Justify” is about defending. Like “explain,” it involves reasoning; unlike “explain,” it also involves opinion and debate. In order to reinterpret the curricular competency “Explain and justify mathematical ideas and decisions,” I will continue to take apart its constituent part “Justify mathematical decisions” and carefully examine the term “mathematical decisions.” What, exactly, is a “mathematical decision”? Below, I will categorize answers to this question. These categories, and the provided examples, may help to suggest new opportunities for students to justify.

Making and Justifying Mathematical Decisions.pdf

Making and Justifying Mathematical Decisions.pdf

Making and Justifying Mathematical Decisions.pdf

The basics of sentences session 2pptx copy.pptx

The basics of sentences session 2pptx copy.pptx

The basics of sentences session 2pptx copy.pptx

PROCESS RECORDING FORMAT.docx

PROCESS RECORDING FORMAT.docx

PROCESS RECORDING FORMAT.docx

Measures of Central Tendency: Mean, Median and Mode

Measures of Central Tendency: Mean, Median and Mode

Measures of Central Tendency: Mean, Median and Mode

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx

Paris 2024 Olympic Geographies - an activity

Paris 2024 Olympic Geographies - an activity

Paris 2024 Olympic Geographies - an activity

This PowerPoint helps students to consider the concept of infinity.

This PowerPoint helps students to consider the concept of infinity.

This PowerPoint helps students to consider the concept of infinity.

christianmathematics

Nutritional Needs Presentation - HLTH 104

Nutritional Needs Presentation - HLTH 104

Nutritional Needs Presentation - HLTH 104

Activity 01 - Artificial Culture (1).pdf

Activity 01 - Artificial Culture (1).pdf

Activity 01 - Artificial Culture (1).pdf

Mehran University Newsletter Vol-X, Issue-I, 2024

Mehran University Newsletter Vol-X, Issue-I, 2024

Mehran University Newsletter Vol-X, Issue-I, 2024

Mehran University of Engineering & Technology, Jamshoro

Holdier Curriculum Vitae (April 2024).pdf

Holdier Curriculum Vitae (April 2024).pdf

Holdier Curriculum Vitae (April 2024).pdf

Unit-IV; Professional Sales Representative (PSR).pptx

Unit-IV; Professional Sales Representative (PSR).pptx

Unit-IV; Professional Sales Representative (PSR).pptx

VishalSingh1417

Accessible design: Minimum effort, maximum impact

Accessible design: Minimum effort, maximum impact

Accessible design: Minimum effort, maximum impact

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes

The global implications of DORA and NIS 2 Directive are significant, extending beyond the European Union. Amongst others, the webinar covers: • DORA and its Implications • Nis 2 Directive and its Implications • How to leverage directive and regulation as a marketing tool and competitive advantage • How to use new compliance framework to request additional budget Presenters: Christophe Mazzola - Senior Cyber Governance Consultant Armed with endless Excel files, a meme catalog worthy of the best X'os (formerly twittos), and a risk register to make your favorite risk manager jealous, I swapped my computer scientist cape a few years ago for that of a (cyber) threat hunter with the honorary title of CISO. Ah, and I am also a quadruple senior certified ISO27001/2/5, Pas mal non ? C'est francais. Malcolm Xavier Malcolm Xavier has been working in the Digital Industry for over 18 Years now. He has worked with Global Clients in South Africa, United States and United Kingdom. He has achieved Many Professional Certifications Like CISSP, Google Cloud Practitioner, TOGAF, Azure Cloud, ITIL v3 etc. His core competencies include IT strategy, cybersecurity, IT infrastructure management, data center migration and consolidation, data protection and compliance, risk management and governance, and IS program development and management. Date: April 25, 2024 Tags: Information Security, Digital Operational Resilience Act (DORA) ------------------------------------------------------------------------------- Find out more about ISO training and certification services Training: Digital Operational Resilience Act (DORA) - EN | PECB NIS 2 Directive - EN | PECB Webinars: https://pecb.com/webinars Article: https://pecb.com/article Whitepaper: https://pecb.com/whitepaper ------------------------------------------------------------------------------- For more information about PECB: Website: https://pecb.com/ LinkedIn: https://www.linkedin.com/company/pecb/ Facebook: https://www.facebook.com/PECBInternational/ Slideshare: http://www.slideshare.net/PECBCERTIFICATION

Beyond the EU: DORA and NIS 2 Directive's Global Impact

Beyond the EU: DORA and NIS 2 Directive's Global Impact

Beyond the EU: DORA and NIS 2 Directive's Global Impact

Sports & Fitness Value Added Course FY..

Sports & Fitness Value Added Course FY..

Sports & Fitness Value Added Course FY..

Web & Social Media Analytics Previous Year Question Paper.pdf

Web & Social Media Analytics Previous Year Question Paper.pdf

Web & Social Media Analytics Previous Year Question Paper.pdf

How to Give a Domain for a Field in Odoo 17

How to Give a Domain for a Field in Odoo 17

How to Give a Domain for a Field in Odoo 17

Último (20)

Gardella_Mateo_IntellectualProperty.pdf.

Gardella_Mateo_IntellectualProperty.pdf.

Gardella_Mateo_IntellectualProperty.pdf.

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"

Making and Justifying Mathematical Decisions.pdf

Making and Justifying Mathematical Decisions.pdf

Making and Justifying Mathematical Decisions.pdf

The basics of sentences session 2pptx copy.pptx

The basics of sentences session 2pptx copy.pptx

The basics of sentences session 2pptx copy.pptx

PROCESS RECORDING FORMAT.docx

PROCESS RECORDING FORMAT.docx

PROCESS RECORDING FORMAT.docx

Measures of Central Tendency: Mean, Median and Mode

Measures of Central Tendency: Mean, Median and Mode

Measures of Central Tendency: Mean, Median and Mode

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx

SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx

Paris 2024 Olympic Geographies - an activity

Paris 2024 Olympic Geographies - an activity

Paris 2024 Olympic Geographies - an activity

This PowerPoint helps students to consider the concept of infinity.

This PowerPoint helps students to consider the concept of infinity.

This PowerPoint helps students to consider the concept of infinity.

Nutritional Needs Presentation - HLTH 104

Nutritional Needs Presentation - HLTH 104

Nutritional Needs Presentation - HLTH 104

Activity 01 - Artificial Culture (1).pdf

Activity 01 - Artificial Culture (1).pdf

Activity 01 - Artificial Culture (1).pdf

Mehran University Newsletter Vol-X, Issue-I, 2024

Mehran University Newsletter Vol-X, Issue-I, 2024

Mehran University Newsletter Vol-X, Issue-I, 2024

Holdier Curriculum Vitae (April 2024).pdf

Holdier Curriculum Vitae (April 2024).pdf

Holdier Curriculum Vitae (April 2024).pdf

Unit-IV; Professional Sales Representative (PSR).pptx

Unit-IV; Professional Sales Representative (PSR).pptx

Unit-IV; Professional Sales Representative (PSR).pptx

Accessible design: Minimum effort, maximum impact

Accessible design: Minimum effort, maximum impact

Accessible design: Minimum effort, maximum impact

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes

Beyond the EU: DORA and NIS 2 Directive's Global Impact

Beyond the EU: DORA and NIS 2 Directive's Global Impact

Beyond the EU: DORA and NIS 2 Directive's Global Impact

Sports & Fitness Value Added Course FY..

Sports & Fitness Value Added Course FY..

Sports & Fitness Value Added Course FY..

Web & Social Media Analytics Previous Year Question Paper.pdf

Web & Social Media Analytics Previous Year Question Paper.pdf

Web & Social Media Analytics Previous Year Question Paper.pdf

How to Give a Domain for a Field in Odoo 17

How to Give a Domain for a Field in Odoo 17

How to Give a Domain for a Field in Odoo 17

Phenytoin

1. ANTIEPILEPTIC DRUH •Phenytoin (Na channel blocker)

2. PHOSPHENYTOIN-PRODRUG •Water soluble prodrug •Administration-IV/IM •Use-Status epilepticus

3. AT TOXIC DOSES(ACUTE HIGH DOSE) Cerebellar symptoms *Ataxia *Vertigo *Nystagmus *Diplopia

4. USES *Generalised tonic-clonic seizure *partial seizure *Antiarrythmic drug *Enhance wound healing *Trigeminal neuralgia

5. ADVERSE EFFECTS •Gum hypertrophy •Hirsutism •Lymphadenopathy •Teratogenic syndrome •Megaloblastic anemia •Hyperglycemia •Osteomalecia/Rickets